| (KRW) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.32T | — |
| Operating expense | — | — |
| Net income | 430.70B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 207940.KS returned -0.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.2% |
| 1 year | -0.7% |
| 5 years | +7.1% |
| All-time high | ₩1,877,331 (Oct 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₩1,000 in 207940.KS would be worth today ›No. Samsung Biologics Co.,Ltd. has not paid a dividend in the past 12 months.
Samsung Biologics Co.,Ltd. is part of the Healthcare sector.
Samsung Biologics Co.,Ltd. has a market cap of 72.82T KRW, based on the latest quote.
Samsung Biologics Co.,Ltd. is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.
